搜索优化
English
网页
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Multiple Sclerosis News Today
3 天
TG developing under-the-skin version of MS therapy Briumvi
TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.
Multiple Sclerosis News Today
3 天
Bayer’s MRI contrast agent effective with 60% less gadolinium: Data
Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...
Multiple Sclerosis News Today
4 天
MS treatments don’t cure my disease; they just make it quieter
For columnist Be, MS treatments are a way to ease his symptoms and make his life more comfortable until a cure is found.
Multiple Sclerosis News Today
4 天
Multiple sclerosis quiz: Test your knowledge
How much do you know about multiple sclerosis (MS)? Test your understanding with this quick quiz and see how well you grasp the basics of MS, including its types, causes, symptoms, and testing.
Multiple Sclerosis News Today
4 天
Healing minds: Managing your mental health with MS
Multiple sclerosis can impact your mental health, but there are ways to protect and support your emotional wellness.
Multiple Sclerosis News Today
4 天
Tech-savvy support: MS must-have apps and tools
Apps for people with multiple sclerosis can help track symptoms and medications and support communication and home ...
Multiple Sclerosis News Today
4 天
Managing the ups and downs of relapsing-remitting MS
Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...
Multiple Sclerosis News Today
4 天
5 stretches for MS spasticity
Stretches for MS spasticity can relieve muscle spasms in the lower part of the body, including the feet, ankles, legs, and ...
Multiple Sclerosis News Today
4 天
Phase 1/2 trial will test cell therapy rese-cel in relapsing, progressive MS
Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈